MiRXES achieves a successful US$1bn-plus HKEx IPO with Mewburn Ellis IP due diligence and FTO support
B2B Case Studies Featuring MiRXES as the Customer
Explore case studies featuring MiRXES as the customer — learn how vendors and partners helped MiRXES solve real business challenges.
A Singapore-headquartered biotechnology company specializing in microRNA technology for early disease detection and precision medicine, developing non-invasive blood-based diagnostic tests for cancers and other diseases.
Case Studies
Showing 1 Success Stories about Software and Services used by MiRXES
No matching case studies
